Primary Congenital Glaucoma

Back

Background

By definition, primary congenital glaucoma is present at birth; however, its manifestations may not be recognized until infancy or early childhood. It is characterized by improper development of the eye's aqueous outflow system, leading to increased intraocular pressure (IOP), with consequent damage to ocular structures, resulting in loss of vision. Although the disease is relatively rare, the impact on visual development can be extreme. Early recognition and appropriate therapy of the glaucoma can significantly improve the child's visual future.

Pathophysiology

Primary congenital glaucoma is restricted to a developmental abnormality that affects the trabecular meshwork. This serves to distinguish it from other childhood glaucomas associated with other ocular and systemic congenital abnormalities, as well as childhood glaucomas that may be secondary to other ocular disorders, such as inflammation, trauma, and tumors.

Epidemiology

Frequency

United States

Primary congenital glaucoma is estimated to affect less than 0.05% of ophthalmic patients and o.o5% of children. Although patients with the disease account for a significantly higher incidence in institutions for the blind, with various studies suggesting from 2-15%.

International

For genetic reasons, the incidence can be much higher, for example, in Saudi Arabia and among Romanian gypsies.

Mortality/Morbidity

The disease is bilateral in approximately 75% of cases.

Race

Congenital glaucoma affects all races

Sex

Male patients are found to have a higher incidence of the disease, comprising approximately 65% of cases.

Age

Primary congenital glaucoma usually is diagnosed at birth or shortly thereafter, and most cases are diagnosed in the first year of life.

History

The classic triad of manifestations, any one of which should arouse suspicion of glaucoma in an infant or young child, includes epiphora, photophobia, and blepharospasm.

Physical

Complete ophthalmologic examination

Externally, changes within the cornea, especially within the first few years of life, provide strong additional support for the diagnosis.

The average horizontal corneal diameter at birth is less than 10.5 millimeters. Distention of the globe in response to elevated intraocular pressure leads to enlargement of the cornea. If the corneoscleral junction is more than 12 millimeters in diameter in the first year of life, it is highly suggestive of glaucoma. Grossly, this is more evident in asymmetric cases. Enlargement of the globe is called buphthalmos.

Corneal edema may be a direct result of the elevated intraocular pressure, producing a corneal haze that clears with normalization of the pressure. Haab striae represent tears in the Descemet membrane as a result of elevated intraocular pressure. In advanced cases, a dense opacification of the corneal stroma may occur secondary to the corneal edema, and it may persist, despite reduction of the intraocular pressure.

The early presence of glaucoma may deepen the anterior chamber. Because of the frequent occurrence of iris abnormalities in many types of both primary and secondary childhood glaucomas, the iris and angles always should be studied carefully and with thorough gonioscopy.

By the time that glaucoma is diagnosed in a child, the optic nerve head is usually abnormal. Variable cupping is present, usually annular in form, with nasalization of vessels and preservation of the well-vascularized rim. Pallor is first seen temporally when present at an advanced stage.

Tonometry often can be accomplished in a child's eye with a handheld instrument, such as a Perkins tonometer or a Tono-Pen. Accuracy of intraocular pressure measurements taken in the office may be artificially elevated from straining.

Causes

Most cases of primary congenital glaucoma are sporadic in occurrence. However, evidence exists suggesting that the disease may be transmitted through an autosomal recessive pattern, with variable penetrance, or a polygenic inheritance pattern. Polygenic inheritance is glaucoma resulting from the interaction of 2 or more nonhomologous genes. Digynically, this has been shown in humans for CYB1B1 and MYOC and in the mouse for CYP1B1 and FOXC1.[1]

CYP1B1, (locus GLC3A) the gene encoding cytochrome P4501B1 (P450, family I, sub family B, polypeptide 1) is associated with primary congenital glaucoma. GLC3B located on band 1p36 and GLC3C located on band 14q24.3 are loci that are linked to primary congenital glaucoma.

The incidence of CYP1B1 in familial cases is 93% in Saudi Arabia, 50% in Brazil, and 20-30% in ethnically mixed populations, and its incidence in nonfamilial (simplex) cases is 10-15%. Mice with this defect have structural abnormalities of the drainage system resembling those seen in humans.

Laboratory Studies

Laboratory methods of diagnosing primary congenital glaucoma include the following:

Imaging Studies

High-resolution anterior segment optical coherence tomography

Other Tests

Examination under anesthesia can supply important information about the childhood patient.

In addition to tonometry, corneal measurements, gonioscopy, and ophthalmoscopy should be performed in the operating room and carefully documented.

Intraocular pressures recorded under general anesthesia are usually lower than those obtained in the office because of the effects of the anesthetic agents. In unilateral cases, asymmetry of otherwise normal intraocular pressures may be diagnostic, along with other signs, such as corneal diameter.

If available in the operating room, pachymetry to quantify corneal edema and A-scan ultrasound to determine axial distention often are useful.[2]

Multiple examinations may be needed before a definitive diagnosis can be made.

Medical Care

Primary congenital glaucoma almost always is managed surgically. Medical therapy is used only as a temporizing measure prior to surgery and to maximize pressure control after surgery.

Surgical Care

The primary surgical techniques are designed to eliminate the resistance to aqueous outflow created by the structural abnormalities in the anterior chamber angle. This may be accomplished through an internal approach with goniotomy or through an external approach with trabeculotomy.

Goniotomy is a technique in which abnormal tissue is incised under direct visualization with the aid of a goniolens. This presumably relieves the compressive traction on the anterior uvea on the trabecular meshwork, which eliminates any resistance imposed by incompletely developed inner trabecular meshwork.

Viscotrabeculotomy (canalotomy) uses a high-viscosity viscoelastic to open the canal.[3]

In trabeculotomy, the Schlemm canal is identified by external dissection, and the trabecular meshwork is incised by passing a probe into the canal and, then, rotating it into the anterior chamber. One advantage of this procedure is that it can be performed in eyes with cloudy corneas, which is not the case with goniotomy.

Both goniotomy and trabeculotomy have their advocates; however, reported success rates for both procedures are approximately 80%. The worst prognosis occurs in infants with elevated pressures and cloudy corneas present at birth. The most favorable outcome is seen in infants operated between the second and eighth month of life. Surgery has been found to be less effective in preserving vision, with increasing age.

When multiple goniotomies and/or trabeculotomies have failed, the surgeon usually resorts to a filtering procedure, such as trabeculectomy. This may be accomplished either with or without antimetabolites. Should these procedures fail, shunts may be used. In those situations, in which all else has failed, ciliary body destructive procedures may be useful.

Further Outpatient Care

The follow-up care of patients with primary congenital glaucoma has several important facets. In the early postoperative period, close observation is required regarding success of the procedure. This may require multiple examinations under anesthesia.

Complications

Serious complications of surgical intervention include hyphema, infection, lens damage, and uveitis.

The most serious complications in children often are caused by general anesthesia. Because of anesthetic risks, bilateral procedures are indicated in some children.

Prognosis

Corneal edema may persist for weeks after successful reduction of the intraocular pressure. Changes in the optic nerve head provide the most important indicator of the course of the disease. Cupping can reverse in successfully treated cases.

The intraocular pressure also is a significant factor in postoperative visual capacity, with substantially better vision among those patients whose pressures remain no higher than 19.

Even when the intraocular pressure is well controlled, approximately 50% of children do not achieve vision better than 20/50.

Reduced visual acuity may result from persistent corneal edema, nystagmus, amblyopia, or large refractive errors.

Patient Education

The patient and family must understand that intraocular pressure elevation can recur at any age in individuals with primary congenital glaucoma, and these patients must receive follow-up care throughout their lives.

For excellent patient education resources, visit eMedicineHealth's Eye and Vision Center. Also, see eMedicineHealth's patient education articles Primary Congenital Glaucoma and Glaucoma Overview.

Author

Gerhard W Cibis, MD, Clinical Professor, Director of Pediatric Ophthalmology Service, Department of Ophthalmology, University of Kansas School of Medicine

Disclosure: Nothing to disclose.

Coauthor(s)

Andrew A Dahl, MD, FACS, Assistant Professor of Surgery (Ophthalmology), New York College of Medicine (NYCOM); Director of Residency Ophthalmology Training, The Institute for Family Health and Mid-Hudson Family Practice Residency Program; Staff Ophthalmologist, Telluride Medical Center

Disclosure: Nothing to disclose.

Robert C Urban, Jr, MD, Medical Director, Glaucoma Associates, Oaklake Medical Center

Disclosure: Nothing to disclose.

Specialty Editors

Simon K Law, MD, PharmD, Clinical Professor of Health Sciences, Department of Ophthalmology, Jules Stein Eye Institute, University of California, Los Angeles, David Geffen School of Medicine

Disclosure: Nothing to disclose.

Martin B Wax, MD, Professor, Department of Ophthalmology, University of Texas Southwestern Medical School; Vice President, Research and Development, Head, Ophthalmology Discovery Research and Preclinical Sciences, Alcon Laboratories, Inc

Disclosure: Nothing to disclose.

Chief Editor

Inci Irak Dersu, MD, MPH, Associate Professor of Clinical Ophthalmology, State University of New York Downstate College of Medicine; Attending Physician, SUNY Downstate Medical Center, Kings County Hospital, and VA Harbor Health Care System

Disclosure: Nothing to disclose.

Additional Contributors

Neil T Choplin, MD, Adjunct Clinical Professor, Department of Surgery, Section of Ophthalmology, Uniformed Services University of Health Sciences

Disclosure: Nothing to disclose.

References

  1. López-Garrido MP, Medina-Trillo C, Morales-Fernandez L, Garcia-Feijoo J, Martínez-de-la-Casa JM, García-Antón M, et al. Null CYP1B1 genotypes in primary congenital and nondominant juvenile glaucoma. Ophthalmology. 2013 Apr. 120(4):716-23. [View Abstract]
  2. Gupta V, Jha R, Srinivasan G, Dada T, Sihota R. Ultrasound biomicroscopic characteristics of the anterior segment in primary congenital glaucoma. J AAPOS. 2007 Dec. 11(6):546-50. [View Abstract]
  3. Tamcelik N, Ozkiris A. Long-term results of viscotrabeculotomy in congenital glaucoma: comparison to classical trabeculotomy. Br J Ophthalmol. 2008 Jan. 92(1):36-9. [View Abstract]
  4. Abu-Amero KK, Deepak PE. Primary Congenital Glaucoma. GeneReviews. Available at http://www.ncbi.nlm.nih.gov/books/NBK1135/. Accessed: August 8, 2013.
  5. Edward DP, Vajaranant TS, Al-Shahwan S, Bejjani BA. A comprehensive update on congenital glaucoma. Curr Ped Rev. Feb 2008. 4(1):19-30.
  6. Mansoor S. Diagnosis of Primary Congenital Glaucoma. March 27, 2001;